Kalaris Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 08/14/2026 | 12.88 M | $52.43 M | -0.52% | 54.13% |
| RTW INVESTMENTS, LP | 08/14/2026 | 1.30 M | $5.29 M | 0.00% | 5.46% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 572.69 K | $2.33 M | 0.00% | 2.41% |
| SIREN, L.L.C. | 08/13/2026 | 435.80 K | $1.77 M | 0.00% | 1.83% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 398.71 K | $1.62 M | 56.14% | 1.68% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 360.00 K | $1.47 M | 0.00% | 1.51% |
| UBS GROUP AG | 08/13/2026 | 262.13 K | $1.07 M | 4,138.86% | 1.10% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 149.35 K | $607.86 K | 125.77% | 0.63% |
| MARSHALL WACE, LLP | 08/13/2026 | 139.20 K | $566.55 K | 105.07% | 0.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 114.04 K | $464.29 K | 30.26% | 0.48% |
| WOODLINE PARTNERS LP | 08/14/2026 | 100.00 K | $407.00 K | 0.00% | 0.42% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 100.00 K | $407.00 K | 0.00% | 0.42% |
| WHI TRUST CO LLC | 08/11/2026 | 97.49 K | $396.80 K | 0.00% | 0.41% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 97.16 K | $395.46 K | -18.27% | 0.41% |
| CITADEL ADVISORS LLC | 09/02/2026 | 95.77 K | $389.79 K | 100.00% | 0.40% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 92.26 K | $375.50 K | 0.00% | 0.39% |
| VERDAD ADVISERS, LP | 08/14/2026 | 80.30 K | $326.81 K | 100.00% | 0.34% |
| MORGAN STANLEY | 08/13/2026 | 72.33 K | $294.37 K | 88.62% | 0.30% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 66.18 K | $269.35 K | 80.24% | 0.28% |
| BLACKROCK, INC. | 08/07/2026 | 54.44 K | $221.58 K | 51.05% | 0.23% |
| BELPOINTE ASSET MANAGEMENT LLC | 07/31/2026 | 40.00 K | $162.80 K | 0.00% | 0.17% |
| FORTIS CAPITAL ADVISORS, LLC | 07/31/2026 | 40.00 K | $162.80 K | 0.00% | 0.17% |
| PALE FIRE CAPITAL SE | 08/13/2026 | 39.63 K | $161.28 K | 100.00% | 0.17% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 38.78 K | $157.81 K | -2.51% | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 32.50 K | $132.28 K | 44.44% | 0.14% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 30.12 K | $122.60 K | 47.66% | 0.13% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 30.01 K | $122.13 K | 119.75% | 0.13% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 29.74 K | $121.03 K | 100.00% | 0.13% |
| STATE STREET CORP | 08/07/2026 | 26.51 K | $107.90 K | 0.00% | 0.11% |
| NORTHERN TRUST CORP | 08/13/2026 | 25.84 K | $105.17 K | 78.83% | 0.11% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 25.00 K | $101.75 K | 38.89% | 0.11% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 23.85 K | $97.06 K | -22.20% | 0.10% |
| WEALTHTRUST ASSET MANAGEMENT, LLC | 07/27/2026 | 20.42 K | $83.09 K | 64.43% | 0.09% |
| INDEPENDENT ADVISOR ALLIANCE | 08/12/2026 | 18.13 K | $73.77 K | 27.37% | 0.08% |
| RBF CAPITAL, LLC | 08/14/2026 | 17.39 K | $70.78 K | 0.00% | 0.07% |
| QUADRATURE CAPITAL LTD | 08/07/2026 | 16.53 K | $67.27 K | 100.00% | 0.07% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 16.05 K | $65.34 K | -85.47% | 0.07% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 15.96 K | $64.99 K | 100.00% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 14.22 K | $57.88 K | -73.01% | 0.06% |
| HRT FINANCIAL LP | 08/14/2026 | 13.72 K | $55.00 K | 18.13% | 0.06% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 08/14/2026 | 12.50 K | $50.88 K | 212.50% | 0.05% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 10.85 K | $44.00 K | 100.00% | 0.05% |
| SIGMA PLANNING CORP | 08/07/2026 | 10.17 K | $41.38 K | 100.00% | 0.04% |
| FMR LLC | 08/13/2026 | 7.81 K | $31.77 K | 0.00% | 0.03% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 5.00 K | $20.35 K | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 2.56 K | $10.42 K | 1,741.73% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 2.22 K | $9.02 K | 0.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 725 | $2.95 K | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 303 | $1.23 K | -94.26% | 0.00% |
| STRENGTHENING FAMILIES & COMMUNITIES, LLC | 08/11/2026 | 268 | $1.09 K | 0.00% | 0.00% |
Kalaris Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 69 institutional investors and hedge funds held shares of Kalaris Therapeutics Inc.. The most heavily invested institutionals were:
Samsara BioCapital, LLC: 12.88 M
RTW INVESTMENTS, LP: 1.3 M
Alyeska Investment Group, L.P.: 572,687
Siren, L.L.C.: 435,798
VANGUARD CAPITAL MANAGEMENT LLC: 398,712
Ikarian Capital, LLC: 360,000
75.79% of Kalaris Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.33 M shares in the last 24 months. This purchase volume represents approximately $183.29 M in transactions.